Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study.

Kuhlmann A, Ólafsdóttir IS, Lind L, Sundström J, Janson C.

BMC Geriatr. 2013 Aug 7;13:82. doi: 10.1186/1471-2318-13-82.

2.

Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth factor as predictors of mortality in nonagenarians: the Vitality 90+ study.

Kämppä N, Mäkelä KM, Lyytikäinen LP, Peltonen N, Hautamäki J, Seppälä I, Mononen N, Goebeler S, Karhunen PJ, Hervonen A, Hurme M, Jylhä M, Lehtimäki T.

Exp Gerontol. 2013 Nov;48(11):1167-72. doi: 10.1016/j.exger.2013.07.009. Epub 2013 Jul 30.

PMID:
23911532
3.

Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland.

Thorleifsson SJ, Margretardottir OB, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gislason T.

Respir Med. 2009 Oct;103(10):1548-53. doi: 10.1016/j.rmed.2009.04.005. Epub 2009 May 7.

5.

Levels and values of inflammatory markers in patients with angina pectoris.

Yip HK, Wu CJ, Hang CL, Chang HW, Yang CH, Hsieh YK, Fang CY, Fu M, Yeh KH, Chen MC.

Int Heart J. 2005 Jul;46(4):571-81.

6.

Systemic inflammation, depression and obstructive pulmonary function: a population-based study.

Lu Y, Feng L, Feng L, Nyunt MS, Yap KB, Ng TP.

Respir Res. 2013 May 15;14:53. doi: 10.1186/1465-9921-14-53.

7.

Systemic inflammation and decline in lung function in a general population: a prospective study.

Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM.

Thorax. 2007 Jun;62(6):515-20. Epub 2007 Jan 24.

8.

Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study.

Margretardottir OB, Thorleifsson SJ, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gislason T.

COPD. 2009 Aug;6(4):250-5.

9.

C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.

Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.

Arterioscler Thromb Vasc Biol. 2002 Apr 1;22(4):593-8.

10.

Associations between lung function and alcohol consumption--assessed by both a questionnaire and a blood marker.

Frantz S, Wollmer P, Dencker M, Engström G, Nihlén U.

Respir Med. 2014 Jan;108(1):114-21. doi: 10.1016/j.rmed.2013.08.041. Epub 2013 Sep 7.

11.

Inflammatory markers in relation to insulin resistance and the metabolic syndrome.

Ingelsson E, Hulthe J, Lind L.

Eur J Clin Invest. 2008 Jul;38(7):502-9. doi: 10.1111/j.1365-2362.2008.01962.x. Epub 2008 May 16.

PMID:
18489581
12.

[Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].

Morales S A, Dreyse D J, Díaz P O, Saldías P F, Carrasco M, Lisboa B C.

Rev Med Chil. 2010 Aug;138(8):957-64. doi: /S0034-98872010000800003. Epub 2010 Nov 26. Spanish.

13.

A gender difference in circulating neutrophils in malnourished patients with COPD.

Larsson S, Nordenson A, Glader P, Yoshihara S, Lindén A, Slinde F.

Int J Chron Obstruct Pulmon Dis. 2011;6:83-8. doi: 10.2147/COPD.S15351. Epub 2011 Jan 17.

14.

Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.

Fang L, Wei H, Mak KH, Xiong Z, Song J, Wang D, Lim YL, Chatterjee S.

Can J Cardiol. 2004 Dec;20(14):1433-8.

PMID:
15614337
15.

Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.

Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y.

Respir Med. 2009 Aug;103(8):1231-8. doi: 10.1016/j.rmed.2009.01.021. Epub 2009 Feb 26.

16.

Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.

Gatta D, Aliprandi G, Pini L, Zanardini A, Fredi M, Tantucci C.

Eur Rev Med Pharmacol Sci. 2011 Sep;15(9):1068-73.

PMID:
22013730
17.

Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.

Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):982-8. doi: 10.1164/rccm.201206-1113OC. Epub 2012 Sep 13.

PMID:
22983959
18.

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.

Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J; EPI-SCAN Steering Committee.

Respir Res. 2010 May 25;11:63. doi: 10.1186/1465-9921-11-63.

19.

Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.

Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A, Powell JT, Lowe GD.

J Vasc Surg. 2006 Mar;43(3):474-80.

20.

The role of serum VCAM-1 and TNF-α as predictors of mortality and morbidity in patients with chronic heart failure.

Savic-Radojevic A, Radovanovic S, Pekmezovic T, Pljesa-Ercegovac M, Simic D, Djukic T, Matic M, Simic T.

J Clin Lab Anal. 2013 Mar;27(2):105-12. doi: 10.1002/jcla.21570. Epub 2013 Jan 24.

PMID:
23349048
Items per page

Supplemental Content

Write to the Help Desk